Gateway Wealth Partners LLC Acquires New Position in Cencora, Inc. $COR

Gateway Wealth Partners LLC acquired a new stake in Cencora, Inc. (NYSE:COR) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 2,198 shares of the company’s stock, valued at approximately $691,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in COR. Kemnay Advisory Services Inc. acquired a new position in Cencora during the fourth quarter worth $25,000. Oakworth Capital Inc. acquired a new stake in Cencora in the fourth quarter valued at $26,000. Elyxium Wealth LLC acquired a new stake in Cencora in the fourth quarter valued at $27,000. Archer Investment Corp boosted its position in shares of Cencora by 134.3% during the 4th quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after purchasing an additional 47 shares in the last quarter. Finally, Motiv8 Investments LLC purchased a new stake in shares of Cencora during the 4th quarter worth $29,000. Institutional investors and hedge funds own 97.52% of the company’s stock.

Cencora Stock Down 1.9%

Cencora stock opened at $312.58 on Friday. The company has a debt-to-equity ratio of 3.40, a quick ratio of 0.59 and a current ratio of 0.95. The firm has a market capitalization of $60.82 billion, a price-to-earnings ratio of 23.97, a price-to-earnings-growth ratio of 1.77 and a beta of 0.58. Cencora, Inc. has a fifty-two week low of $244.82 and a fifty-two week high of $377.54. The stock’s fifty day moving average is $288.61 and its two-hundred day moving average is $315.62.

Cencora (NYSE:COR) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The firm had revenue of $78.36 billion during the quarter, compared to analysts’ expectations of $81.09 billion. During the same quarter in the prior year, the business earned $4.42 EPS. The company’s quarterly revenue was up 3.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Analysts predict that Cencora, Inc. will post 17.79 EPS for the current fiscal year.

Cencora declared that its Board of Directors has authorized a share buyback program on Thursday, May 21st that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the company to purchase up to 3.9% of its shares through open market purchases. Shares buyback programs are often an indication that the company’s board of directors believes its stock is undervalued.

Cencora Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were issued a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.8%. The ex-dividend date was Friday, May 15th. Cencora’s dividend payout ratio (DPR) is 18.40%.

Insider Transactions at Cencora

In other Cencora news, Director Lauren M. Tyler bought 550 shares of the business’s stock in a transaction on Monday, June 22nd. The stock was bought at an average price of $270.23 per share, for a total transaction of $148,626.50. Following the completion of the transaction, the director owned 4,359 shares in the company, valued at approximately $1,177,932.57. The trade was a 14.44% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.38% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the stock. Evercore set a $360.00 price target on shares of Cencora in a report on Wednesday, April 8th. William Blair started coverage on shares of Cencora in a research note on Tuesday, April 28th. They issued a “market perform” rating for the company. Bank of America boosted their price objective on shares of Cencora from $280.00 to $285.00 and gave the stock a “neutral” rating in a report on Wednesday, June 24th. Citigroup lowered their target price on shares of Cencora from $405.00 to $355.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. Finally, Morgan Stanley set a $342.00 target price on shares of Cencora in a report on Friday, May 8th. Eleven equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, Cencora presently has an average rating of “Moderate Buy” and a consensus price target of $367.75.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.